Objective: The present study is focused on optimization of elastic liposomes-in-vehicle formulations in respect to drug release and formulation properties. By combining penetration potential of elastic liposomes containing high ratio of entrapped drug and physicochemical properties of vehicles, both affecting the release and texture properties, optimal formulation could be achieved.
INTRODUCTION
Effective (trans)dermal drug delivery depends on both the selection of an appropriate drug and the properties of the delivery system (vehicle). Vehicles exert pronounced effects on the epidermis, affecting hydration, lubrication, drying, skin smoothness, occlusion and protection.
In addition, the physicochemical properties of vehicles influence the pharmacokinetic properties of the incorporated drug by controlling its release from the vehicle and affecting penetration through the stratum corneum, permeation through the layers of skin and absorption into the blood. Therefore, interactions between the vehicle, skin and drug can influence the final therapeutic effect of the applied formulation 1, 2 . For this reason, the selection of an appropriate vehicle is an important factor in increasing the efficacy of a topically applied drug 3, 4 .
Despite the numerous types of available vehicles, dermal and particularly transdermal delivery of hydrophilic drugs is limited by the barrier nature of the outermost layers of the epidermis. Various strategies have been explored to enhance transdermal drug delivery, including adjustment of stratum corneum permeability by chemical penetration enhancers and electrical/external force methods, such as iontophoresis, sonophoresis and electroporation 5 .
During the last two decades, considerable attention has been focused on developing nanodelivery systems that facilitate changes of the pharmacokinetic properties of a given drug and increase its bioavailability 6 . Because they are physiologically acceptable, phospholipid vesicles (liposomes) have shown great potential for improving the topical delivery of hydrophilic drugs. While conventional liposomes generally enhance skin deposition of the drug without affecting percutaneous permeation and transdermal delivery 7 , new classes of phospholipid vesicles, such as deformable (flexible, elastic) liposomes [8] [9] [10] , ethosomes 11 , invasomes 12 and propylene glycol-containing liposomes 13 , have been shown to increase the transport of active substances through the stratum corneum into the deeper layers of skin and even transdermally. Despite these advantages, topical application of liposomes can be restricted by their liquid nature. Thus, they must be incorporated into a suitable vehicle 14 . In addition to increasing the viscosity and preserving physical stability of conventional liposomes incorporated into hydrogels [15] [16] [17] [18] , dermatological vehicles could affect drug bioavailability and play an important role in the care and maintenance of skin health 2 .
In the previous study 19 , we optimized the preparation conditions and evaluated the skin 
Preparation and characterization of liposomes
Deformable, propylene glycol and conventional liposomes were prepared by the film hydration method, followed by extrusion, as previously described 19 . Briefly, lipid components were dissolved in concentrated ethanol in a round bottomed flask. The ethanol was removed The mean diameters, size distributions (polydispersity) and zeta potentials of the liposomes were determined by photon correlation spectroscopy (Zetasizer 3000HS, Malvern
Instruments, Malvern, UK) 20, 21 . Membrane elasticity of extruded liposomes was evaluated by home-made device at an external pressure of 5 bar using 100-nm membranes. Detailed procedure with equation for calculation of the deformability degree (E) has been previously described in details 14, 19 . Separation of the unentrapped drug was performed using gel chromatography on Sepharose CL-4B 22 . Thereafter, the liposomal fraction was concentrated using ultracentrifugation as previously described 19 . The concentrations of both the unentrapped (free) and liposome-entrapped drug were determined spectrophotometrically (Ultrospect Plus, Pharmacia LKB, Cambridge, UK). The concentrations of free diclofenac sodium were measured at 276 nm (demineralized water), and the entrapped drug was detected at 282 nm after the liposomes were dissolved in methanol.
2.3.
Preparation of semi-solid vehicles 2.3.1. Hydrogel
Carbopol 980 NF (0.5 g) was dispersed in demineralized water (88.5 g) using a magnetic stirrer (700 rpm) for 60 minutes. Propylene glycol (10 g) was then added, and the mixture neutralized by the addition of 50% (w/w) triethanolamine in an amount sufficient to achieve a gel of pH 6 23 .
Cream base
The cream base was an oil-in-water (O/W) emulsion prepared using the modified procedure of Betz and coworkers 24 . Briefly, the lipophilic phase components [glycerol monostearate (4 g ), cetylalcohol (6 g), Miglyol 812 (7.5 g), vaselinum album (25. 
2.5.
In vitro drug release studies
The release of the drug from the liposomes incorporated into different vehicles was determined by the method originally introduced by Pesckha et al. 25 and adapted for liposomal hydrogels 14, 16, 23 . Briefly, samples of the liposomes-in-vehicle formulations (3 g) were placed in glass vials and separated from 5 mL of receptor solution (distilled water) by a 2% (w/w) agarose layer, which permitted diffusion of both the released drug and intact liposomes from liposomes-in-vehicles (donor compartment). The vials were incubated at 32 °C, and the receptor solution was completely replaced at specific time intervals. The amount of the drug released was determined spectrophotometrically (before and after the addition of methanol).
Controls were examined under the same conditions.
The concentration of the drug was determined spectrophotometrically as described above.
Texture analysis of the liposomes-in-vehicle formulations
A Texture Analyzer TA.XT Plus (Stable Micro Systems Ltd., Surrey, UK) was used to examine the texture properties of the liposomes-in-vehicle formulations. Fifty grams of each formulation was placed in a standard beaker, ensuring that no air bubbles were included and that the surface was smooth. A disk (40 mm in diameter) was pushed into the formulation (10 mm at a speed of 1 mm/s, respectively) and removed. Each formulation was measured five times, ensuring the same conditions for each measurement. The hardness of the each formulation was determined, and the texture properties, such as cohesiveness and adhesiveness, were calculated 26 . Control samples were examined under the same conditions.
Statistical analysis
Statistical analysis was performed using a one-way ANOVA, followed by Tukey's multiparametric post hoc test, and p < 0.05 was considered the minimum level of significance.
Calculations were performed with the GraphPad Prism program, version 5.01 (GraphPad Software, Inc., San Diego, CA).
RESULTS AND DISCUSSION

Characterization of liposomes
Composition of the liposomes used as topical drug carrier is known to influence their physicochemical properties and therefore their efficacy as drug delivery system 27, 28 . To allow deeper penetration of the hydrophilic drug into/through the skin, we prepared two types of elastic liposomes and compared them with each other and with conventional liposomes with respect to the following physicochemical properties: size, charge, membrane elasticity and entrapment capacity for diclofenac sodium ( propylene glycol increased the degree of membrane elasticity, which was nearly equal to that of the deformable liposomes (Table 1 ). This result may be explained by the ability of propylene glycol to solubilize phospholipids and intercalate into the bilayer 13, 31, 32 , affecting the membrane flexibility of the vesicles. Regarding the surface charge, all of the liposomes had highly negative zeta potentials (> -50 mV), indicating the formation of physically stable liposome suspensions, which was confirmed in the storage stability studies 19 .
Liposomes-in-vehicle formulations
Appropriate viscosity of liposomes used for skin application can be achieved by incorporation into dermatological vehicles 15 . Vehicle composition has been shown to influence the release properties of the incorporated drug and the penetration ability across/into the skin and may also improve the skin condition 3, 4, 33 . To examine the effect of the vehicle on the release of liposomally entrapped diclofenac sodium, different types of liposomes were incorporated into the following vehicles: the hydrogel, the cream base (O/W emulsion) and DMS base.
To follow the release of diclofenac sodium from the liposomes-in-vehicle formulations, we applied a so-called agarose method that has been shown to be very useful in evaluating drug release from liposomal vaginal gels 14, 16, 23 . The porosity of the agarose matrix permitted both intact liposomes and released (free) drug to diffuse through the matrix into the receptor solution, and the amount of drug released from the vehicle was determined spectrophotometrically before and after the addition of methanol to the supernatant over the agarose matrix 16 . With this method, the amount of intact liposomes released from the vehicle into the receptor medium can be determined, which is not feasible using the Franz diffusion cell method. Moreover, this method provides insight into the possible mechanisms of drug release from liposomes-in-vehicle formulations, which have been proposed to be based on the following four interconnected processes: leakage of the drug inside the vehicle, diffusion of the released drug to the receptor compartment, diffusion of intact liposomes from the vehicle into the receptor solution and release of the liposomally entrapped drug inside the receptor compartment 34 .
The release of diclofenac sodium from the various liposomes-in-vehicle formulations is presented in Table 2 and Figure 1 . The results (Table 2) cases; the drug release from propylene glycol liposomes and especially deformable vesicles was significantly faster (p < 0.05). These results were in agreement with the previous study 19 ,
where the highest release of the drug was achieved from deformable, followed by propylene glycol-containing liposomes, while the slowest release was demonstrated by conventional liposomes.
The release of diclofenac sodium from all of the investigated formulations followed the Higuchi diffusion model 35 , which was confirmed by the good correlation coefficients ranging from 0.988 to 0.995 (Figure 1 ). This finding indicates that the rate-controlling step in the release process was the diffusion of the leaked drug through the vehicle network to the receptor medium, which was affected by both the composition of the phospholipid vesicles and the mechanical properties of the vehicles. Thus, after 24 hours of incubation of liposomes in hydrogel at 32 °C, more than 35% of the drug was released from each formulation of elastic vesicles, while the lowest ratio of released drug (28%) was observed for the conventional liposomes (p < 0.05).
Although the fastest drug release profile from the liposomes-in-vehicle formulations was with DMS base, the highest release of the solution of the drug in vehicle (control) was achieved with the hydrogel (p < 0.05). These results were expected to some extent given the hydrophilic properties of both the drug and the hydrogel. Diclofenac sodium has a dissociation constant (pKa) of 3.9 at 25 °C in water and a log P of 1.45 36 . The hydrogel used in this study contained 89% water and 10% propylene glycol, which acts as both a humectant and a skin-penetration enhancer. Therefore, encapsulation into liposomes extended the release of the drug from the hydrogel.
An evaluation of intact liposome release from the hydrogel and the cream base showed a similar release ratio of both deformable and propylene glycol liposomes compared with conventional liposomes (p < 0.05), which can be attributed to effect of the degree of membrane elasticity of the vesicles (Table 1 ) on the penetration of the liposomes through the vehicle and agarose matrix into the receptor solution (Table 2) . Although propylene glycol liposomes had the same bilayer composition as conventional liposomes, they contained propylene glycol, a well-known skin-penetration enhancer 37, 38 that has been shown to contribute to membrane elasticity (Table 1) were the most promising formulation for improving the topical delivery of diclofenac sodium.
The success of dermatotherapy depends also on the properties of the formulation, particularly the spreading ability and retention of the formulation on the skin 18 . Texture analysis was used to evaluate the mechanical properties of the different liposomes-in-vehicle formulations, and parameters such as hardness, adhesiveness and cohesiveness were assessed ( Figure 2 ). These properties have been directly correlated with administration parameters in vivo, such as spreadability (hardness) and retention of the formulation on the skin (adhesiveness) or its removal from the container (cohesiveness) 14, 26 . Therefore, these investigations are of major importance during the development and optimization of formulations. In addition, they provide valuable data on the compatibility of the incorporated liposomes with the vehicle.
As shown in Figure 2 , the texture characteristics were significantly different between all of the examined vehicles. The cream base showed highest values of all of the parameters assessed, followed by the hydrogel and DMS base. The cream base used in this study contained vaselinum album and cetylalcohol, which were responsible for the hardness of the formulation. Mixing the liposomes in the cream base significantly (ANOVA, p < 0.05) lowered the initial hardness by approximately 30% for the conventional and propylene glycol liposomes and slightly more for the deformable liposomes (35%) (Figure 2 A) .
Conventional liposomes have already been proven to be compatible with Carbopol gels 15, 23 .
Stability of liposomes incorporated in vehicle, especially emulsion and lamellar types of vehicle could be influenced by the vehicle's ingredients. DMS base is a novel cream-like vehicle used in corneotherapy that is prepared without classic emulsifiers and contains lipids similar to those found in human stratum corneum. It is composed of hydrogenated soy phosphatidylcholine, medium chain trigylcerides, phytosterols and squalane 39 . Clinical studies have confirmed increased levels of skin hydration and reparation of disrupted skin barriers with DMS base when used alone or with incorporated active ingredients 39, 40 . Although it has been shown that liposomally encapsulated active compounds mixed in DMS base can significantly improve skin conditions (more than free active compounds in the vehicle) 39 , our results, which were based on texture analysis, indicate a possible physical instability of liposomes in DMS base. A nearly 2-fold decrease of the initial hardness was observed after incorporation of the liposomes into DMS base (more than 60%, regardless of the type of liposome). In contrast, mixing a solution of the free drug (control) into DMS base reduced the initial hardness by only 20% (Figure 2A) . Therefore, we speculate that there may be an interaction/incompatibility between all of the types of liposomes used in this study and DMS Vehicle composition has been shown to play an important role in spreading and retaining the formulation at the application site 42 and in the release profile of the incorporated drug 4 .
Phospholipid vesicles with pronounced elastic properties have been demonstrated to considerably improve transdermal delivery of hydrophilic drugs 7, 8, 43 . By combining penetration potential of elastic liposomes containing high ratio of entrapped drug and physicochemical properties of vehicles, both affecting the release and texture properties, optimal formulation could be achieved. Therefore, propylene glycol liposomes in a hydrogel is considered as the most promising formulation for improving topical delivery of the hydrophilic drug. 
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